Skip to main content
. 2014 Aug 19;111(7):1381–1390. doi: 10.1038/bjc.2014.420

Figure 3.

Figure 3

Kaplan–Meier survival analysis. (A) RCC disease-specific survival (DSS) by 9p deletion status. (B) Recurrence-free survival (RFS) in localised RCC by 9p deletion status. (C) Disease-specific survival (DSS) in locally advanced non-metastatic RCC (pT3N0M0) by 9p deletion status.

HHS Vulnerability Disclosure